Cargando…
Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?
The development of personalised therapies has ushered in a new and exciting era of cancer treatment for a variety of solid malignancies. Yet pancreatic ductal adenocarcinoma (PDAC) has failed to benefit from this paradigm shift, remaining notoriously refractory to targeted therapies. Chemotherapy is...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355171/ https://www.ncbi.nlm.nih.gov/pubmed/27845911 http://dx.doi.org/10.18632/oncotarget.13309 |